Evidence map›Paper›PMID 34761118›Full record

ArticleOpen medicine (Warsaw, Poland)2021

Effects of remifentanil and propofol on distant organ lung injury in an ischemia-reperfusion model.

Orhan Kanbak, Burcu Aydoğan, Tülin Gümüş

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07094165 (Evaluation of the Effects of Remifentanil and Dexmedetomidine on Crush Injury and Renal Functions in an Experimental Model), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07094165 nacompletednot on this mapstarted 2024, after this paper: background citation

Evaluation of the Effects of Remifentanil and Dexmedetomidine on Crush Injury and Renal Functions in an Experimental Model

TypeinterventionalSponsorAnkara City Hospital BilkentRan2024 to 2025Enrolled28ConditionsAcute Kidney Injury, Crush Injury, RhabdomyolysisArmsDexmedetomidine, Remifentanil, Laparotomy, Compression
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Orhan KanbakAnesthesiology and Reanimation Department, Ankara City Hospital, Mutlukent mh. 2023 sok. No: 13 Çankaya, Ankara 06800, Turkey.
Burcu AydoğanAnesthesiology and Reanimation Department, İstanbul Metin Sabancı Baltalimanı Bone Diseases Education and Research Hospital, İstanbul, Turkey.
Tülin GümüşAnesthesiology and Reanimation Department, Ankara City Hospital, Ankara 06800, Turkey.
Türk Anesteziyoloji ve Reanimasyon Derneği · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our aim was to evaluate lung injury due to oxidative stress and antioxidant activity levels in an infrarenal ischemia-reperfusion model and to compare prevention effects of single and combined use of propofol and remifentanil. In this study, a total of 40 adult Wistar Albino rats were randomly divided into five groups of eight rats as SHAM, physiological saline, intraperitoneal propofol, remifentanil, and propofol and remifentanil groups. Blood and tissue samples were obtained after 80 min of reperfusion. The malondialdehyde (MDA) level, a measure of lipid peroxidation, was measured in lung tissue samples and red blood cells; additionally, total oxidant status and total antioxidant capacity of lung tissues were measured and histopathological examination was performed. Distant organ (lung) injury developed due to lower extremity ischemia-reperfusion was created by infrarenal aortic clamping. The lipid peroxidation product MDA and total oxidant levels were increased, but there was insufficient antioxidant protection both in the lung tissues and red blood cells. While propofol prevented this injury consistent with its proposed antioxidant properties; no protective effect of remifentanil was observed. On the contrary, it showed oxidative stress increasing effect. This study concluded that the antioxidant effect of propofol was suppressed by remifentanil in the case of combined use.

Indexed as

anestheticsintravenousischemia–reperfusion injuryoxidative stress

Identifiers

PMID34761118
PMCPMC8576613
OpenAlexW3213114406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.